Fisher & Paykel Healthcare Corp Ltd
Overview
The company is a New
Zealand-based designer, manufacturer and a marketer of products and systems for
use in respiratory care, acute care and the treatment of obstructive sleep
apnea. These products and systems are sold in around 120 countries worldwide. Its
segments include North America, Europe, Asia-Pacific and New Zealand. In
homecare the company is developing its range of devices with completion of the
worldwide introduction of both its F&P ICON flow generator range for the
treatment of obstructive sleep apnea, the introduction of its F&P Pilairo
nasal pillows mask and development of the second generation AIRVO2 humidity
therapy device.
The company entered the
respiratory care market in 1971 with the development of a unique respiratory
humidifier system for use in critical care. It sells its products through
direct sales offices operations in most of its major markets and a network of
distributors that sell to hospitals, homecare providers and other manufacturers
of medical devices.
History
In 1934 the Fisher & Paykel
started its business as an importer of refrigerators, washing machines and
radios. In the year of 1938 it signed an agreement with Kelvintor and in middle
1950 moved to manufacturing products using the company’s own technology. The
healthcare involvement started in the late 1960s. At that time F&P sought
involvement in a business that could benefit from their growing manufacturing
and electronic expertise. There is a prototype respiratory humidifier,
developed in the country for use with patients needing ventilation in hospital
intensive care situations, was taken to production by F&P.
Since the company has
consistently developed innovations to improve patient care and developed
world-wide distribution for the products. On November 2001, as part of
reorganization, Fisher & Paykel Industries Limited was renamed as Fisher
& Paykel Healthcare Corporation Limited and a new company, Fisher &
Paykel Appliances Holdings Limited, was established to own F&P’s appliances
and finance business.
Announcements
On May 23, 2013 the F&P
Healthcare rose 2.6 percent to NZ$3.11, its highest since May 2011. Earlier,
the company reported a 20% rise in profit to NZ$77.1 million in the year to
March, exceeding company and market forecasts for NZ$75 million, and forecast
profits around NZ$85 million-NZ$90 million for 2014.
On August 27, 2013 the company
which makes patient warmers and products to tret breathing disorders, forecast
a profit of NZ$90 million to NZ$95 million ($70.3 million to $74.2 million) for
the year ended March 31, based on an exchange rate of $0.8000. it had
previously forecast a profit range of NZ$85 million to NZ$90 million.
Dividend History
The Fisher & Paykel
Healthcare Corp Ltd currently has a market capitalization of 1.99 Billion, EPS
is 0.14, P/E ratio is 26.72 and the dividend yield is 3.37% at the annual
dividend payout of 0.07.
Conclusion
The company is currently one of
the best leading New Zealand dividend stocks which are performing well
from past five years. Its consistent growth strategy is to provide an expanding
range of innovative medical devices which can help to improve care and outcomes
for patients in an increasing range of applications.
Find more data about Best
dividend paying stocks in New Zealand from the site http://nz.dividendinvestor.com/
No comments:
Post a Comment